|
|
||||||||
Ann Thorac Surg 1998;66:417-424
© 1998 The Society of Thoracic Surgeons
a Centre de Recherches Chirurgicales Henri Mondor, Créteil, France
b Pharmacie Centrale, Hôpital Henri Mondor, Créteil, France
Accepted for publication February 27, 1998.
Address reprint requests to Dr Loisance, Centre de Recherches Chirurgicales Henri Mondor, Faculté de Médecine, 8 rue du Général Sarrail, 94010 Créteil Cedex, France
e-mail: (loisance{at}univ-paris12.fr)
Background. Myocardial preservation for heart transplantation relies on hyperkalemic cardiac arrest and hypothermic storage. Our study investigated whether pretreatment with a potassium-channel opener (cromakalim) before prolonged storage in an extracellular fluid improves left ventricular recovery.
Methods. Rabbit hearts were submitted to 6-hours cold storage and assessed on a blood-perfused isolated heart preparation. Hemodynamic recovery, enzyme release (creatine kinase and lactate dehydrogenase), and adenine nucleotide content were determined. Five groups were tested: control (n = 6), no ischemia; UW group (n = 7), hearts arrested with and stored in University of Wisconsin solution; STH group (n = 5), hearts arrested with and stored in St. Thomas Hospital solution; cromakalim group (n = 6), hearts pretreated with cromakalim (30 µg/kg) before arrest with and storage in St. Thomas Hospital solution; and glibenclamide group (n = 5), hearts pretreated with cromakalim followed by glibenclamide (a potassium-channel blocker) before arrest with and storage in St. Thomas Hospital solution.
Results. Hemodynamic recovery was improved and enzyme release was lower in the UW group than in the STH group. Compared with the STH group, the group pretreated with cromakalim had significantly decreased left ventricular end-diastolic pressures, increased left ventricular developed pressures, increased maximal values of positive and negative rates of rise of left ventricular pressure, and increased time constant of isovolumetric relaxation. Hemodynamic recovery was similar in the UW group and cromakalim groups. Glibenclamide did not abolish the effects of cromakalim. None of the protocols affected myocardial energy stores.
Conclusions. Pretreatment with cromakalim affords additional protection to that provided by cardioplegic arrest and prolonged cold storage using an extracellular solution. The intracellular mechanisms involved remain to be determined.
This article has been cited by other articles:
![]() |
D. M. YELLON and J. M. DOWNEY Preconditioning the Myocardium: From Cellular Physiology to Clinical Cardiology Physiol Rev, October 1, 2003; 83(4): 1113 - 1151. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Ren, Q. Yang, H. S. Floten, A. P. Furnary, A. P.C. Yim, and G.-W. He ATP-sensitive potassium channel openers may mimic the effects of hypoxic preconditioning on the coronary artery Ann. Thorac. Surg., February 1, 2001; 71(2): 642 - 647. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Yellon and A. Dana The Preconditioning Phenomenon : A Tool for the Scientist or a Clinical Reality? Circ. Res., September 29, 2000; 87(7): 543 - 550. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Penta de Peppo, P. Polisca, F. Tomai, R. De Paulis, F. Turani, E. Zupancich, L. Sommariva, P. Pasqualetti, and L. Chiariello Recovery of LV contractility in man is enhanced by preischemic administration of enflurane Ann. Thorac. Surg., July 1, 1999; 68(1): 112 - 118. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kirsch, S. Bertrand, J.-P. Garnier, C. Fernandez, C. Baufreton, A. Astier, and D. Loisance Pretreatment with a potassium-channel opener before prolonged cardiac storage: an evaluation in an experimental brain death model Ann. Thorac. Surg., June 1, 1999; 67(6): 1623 - 1629. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |